Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects



Rating:

Share or cite this content

Citations should be made in the following way:
B. García Cosío Piqueras (Palma de Mallorca, Spain), H. Shafiek (Alexandria, Egypt), N. Toledo-Pons (Palma de Mallorca, Spain), A. Iglesias (Palma de Mallorca, Spain), M. Barcelo (Palma de Mallorca, Spain), C. Represas-Represas (Vigo, Spain), L. Comeche (Madrid, Spain), P. Catalán (Castellón, Spain), A. Fernández-Villar (Vigo, Spain), J. Lopez-Campos (Sevilla, Spain), J. Echave-Sustaeta (Madrid, Spain), J. Soler-Cataluña (Valencia, Spain). Characterization of COPD admissions during the first COVID-19 outbreak. 964

Member's Comments

No comment yet.

Related content which might interest you: Reduction in hospital admissions for Acute Exacerbations of COPD during COVID-19 pandemic Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Characteristics of patients admitted to a respiratory hospital due to COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005 NIV for preventing hospital admissions for COPD exacerbations Source: International Congress 2015 – Long-term non-invasive ventilation (NIV) in COPD Year: 2015 Characteristics of COPD exacerbations in Greece Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Profile of patients hospitalized with COPD acute exacerbation in respiratory department in Tunisia Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Impact of pneumonia on mortality and length of stay in patients hospitalized with acute COPD exacerbations Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Influence of previous admissions on audit outcomes in patients admitted with acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Does impact of COVID-19 pandemic reduce A&E attendances, hospital inpatient stays and re-admissions with acute exacerbation of COPD? Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Change of inhaled medications during hospital admissions for acute exacerbation of COPD Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Inter-regional variability in hospital admissions in COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Characterisation of patients with COPD in Scotland Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Are we over-prescribing antibiotics in acute hospital admissions for exacerbations of COPD? Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Analysis of the causes for the frequent exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Smog episode in Poland in January 2017 as a risk factor of increased hospital admissions due to respiratory and cardiovascular exacerbations Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017 Predictors of frequent hospitalisations for exacerbations in COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018 Year: 2019 Influence of air pollution on hospital admissions in patients with COPD or asthma exacerbation. Source: Virtual Congress 2020 – Air pollution considerations Year: 2020 Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit Source: ERJ Open Res 2016 Year: 2016 Impact of COVID-19 on COPD and Asthma admissions and the pandemic from a patient’s perspective Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021